Physio-pathologic assessment to stratify risk

A. Aliverti (Milan, Italy)

Source: International Congress 2019 – PG14 Perioperative management of fragile patients undergoing major thoracic surgery
Session: PG14 Perioperative management of fragile patients undergoing major thoracic surgery
Session type: Postgraduate Course
Number: 159
Disease area: -

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Aliverti (Milan, Italy). Physio-pathologic assessment to stratify risk. International Congress 2019 – PG14 Perioperative management of fragile patients undergoing major thoracic surgery

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Blood biomarker algorithms to guide COPD assessment and risk stratification
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017



How to stratify the risk of failure of noninvasive respiratory assistance
Source: Virtual Congress 2020 – Noninvasive respiratory assistance for acute respiratory failure outside the intensive care unit: a bargain or a burden?
Year: 2020


Spirometry for the risk stratification of cardiovascular disease among the elderly
Source: Eur Respir J 2007; 30: Suppl. 51, 311s
Year: 2007

Mortality risk prediction in COPD by a prognostic biomarker panel
Source: Eur Respir J 2014; 44: 1557-1570
Year: 2014



Which type of pre-operative risk assessment for which patients
Source: Annual Congress 2012 - Current challenges in multimodality lung cancer treatment
Year: 2012


Harvesting biomarkers for early risk assessment
Source: Annual Congress 2008 - New age lung carcinogenesis: clinical impact
Year: 2008


Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score
Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016
Year: 2017



Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis.
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Individual risk and prognostic factors for asthma according to the natural history of the disease
Source: Annual Congress 2003 - Risk factors for asthma
Year: 2003


Occupational risk factors may be of importance to define populations suitable to screening of lung cancer
Source: Annual Congress 2011 - Work, the environment and respiratory disease
Year: 2011

Mortality after hospitalisation for COVID19, and identification of prognostic factors on admission that increase mortality risk
Source: Virtual Congress 2021 – COVID - 19
Year: 2021


Prevalence of COPD in the general population according to cardiovascular risk factors
Source: Eur Respir J 2007; 30: Suppl. 51, 778s
Year: 2007

Are biomarkers helpful in sepsis for risk assessment or clinical trials?
Source: Annual Congress 2011 - Molecular biomarkers at the bedside of critically ill patients
Year: 2011

Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020
Year: 2020



An innovative risk score for prediction of asthma related adverse outcome
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009


Development and validation of a screening algorithm for perioperative risk of complications in patients suspected with OSA.
Source: International Congress 2018 – Diagnostics including questionnaires
Year: 2018


Incidence and specific risk factors of falling in pulmonary rehabilitation
Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention
Year: 2010